Glaukos (GKOS) Return on Invested Capital (2015 - 2022)
Glaukos (GKOS) posted quarterly Return on Invested Capital of 0.0% for Q1 2022, little changed year-over-year from 0.0% in Q1 2021, and up 50.31% quarter-over-quarter from 0.0% in Q4 2021.
Glaukos (GKOS) Return on Invested Capital (2015 - 2022) Analysis & Trends
Glaukos (GKOS) has reported Return on Invested Capital for 5 consecutive years, with 0.0% the latest figure, recorded in Q1 2022.
- In Q1 2022, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2022 stood at 0.0% (changed 0.0% YoY), while the FY2015 annual figure was 0.01%, changed N/A from the prior year.
- Return on Invested Capital grew to 0.0% in Q1 2022 per GKOS's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q1 2022 and bottomed at 0.0% in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.04% |
| 10 | Glaukos | 10.91 Bn | 10.80 Bn | 151.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |